30th ECCMID – European Congress of Clinical Microbiology & Infectious Diseases
April 18, 2020 - April 21, 2020
The ECCMID 2020 has unfortunately been cancelled due to the extraordinary situation linked to the coronavirus pandemic. We wish you all to be safe and healthy.
If you have any questions regarding Mobidiag solutions, please contact us. We hope to see you all next year at ECCMID 2021!
The 30th ECCMID will take place in Paris, France.
Meet our team on 18 – 21 April 2020 at booth 126 and follow demos of our molecular diagnostics solutions Amplidiag® and Novodiag®.
Mobidiag will be hosting an Integrated Symposium during the ECCMID 2020.
“Improving clinical value through innovative molecular diagnostics“
Sunday April 19th, 16.15 – 18.15
Paris Convention Center, Porte de Versailles, Hall K
OPENING REMARKS
Sohvi Hörkkö, Polona Maver Vodicar
Novel molecular approach for the detection of carbapenemases producing germs
Vittorio Sambri, MD, PhD, Associate Professor, University of Bologna, Italy
Comparison study of two qualitative assays in
the detection of carbapenemase resistance markers
Shova Sharma – Associate Practitioner, BVSc, MSc, MIBMS,
Nottingham University Hospitals, UK
Contribution of molecular biology to the diagnosis of stool parasitosis
Alexis Valentin, Professor, MD, PhD, University Hospital of Toulouse, France
Molecular methods for the diagnosis of meningitis and encephalitis
Dr Mark Wilks, Barts Health Trust and Queen Mary University of London, UK
Diagnostic accuracy of a non-invasive test for the detection of Helicobacter pylori and resistance to clarithromycin in stool by Real-Time PCR
Maxime Pichon, MD, PhD, University Hospital of Poitiers, France
Q&A, CLOSING REMARKS
Sohvi Hörkkö, Polona Maver Vodicar
CHAIR
Sohvi Hörkkö, Professor, MD, PhD, MBA, University of Oulu, Finland
ESCMID-APPOINTED CHAIR
Dr Polona Maver Vodicar, University of Ljubljana, Slovenia